Search results
Anavex (AVXL) Falls 35% on Mixed Rett Syndrome Study Results
Zacks via Yahoo Finance· 6 months agoAnavex (AVXL) falls 35% on mixed results from the mid to late-stage study of 30 mg ANAVEX2-73 for...
Anavex (AVXL) Up 12% on Regulatory Update for Alzheimer's Drug
Zacks via Yahoo Finance· 7 months agoAnavex (AVXL) announces an encouraging regulatory update for its investigational candidate,...
Anavex's (AVXL) Lead Alzheimer's Drug Meets Study Goal
Zacks via Yahoo Finance· 2 years agoTop-line data from a phase IIb/III study shows that Anave's (AVXL) lead drug exhibited statistical...
Anavex (AVXL): Strong Industry, Solid Earnings Estimate Revisions
Zacks via Yahoo Finance· 5 months agoOne stock that might be an intriguing choice for investors right now is Anavex Life Sciences Corp....
Global Blood (GBT) Initiates Phase II Study on SCD Candidate
Zacks via Yahoo Finance· 2 years agoGlobal Blood Therapeutics (GBT) initiates the phase II portion of its planned phase II/III studies...
Why Endo (ENDP) Stock Wilted After its Surge on Tuesday?
Zacks via Yahoo Finance· 2 years agoEndo International (ENDO) tanks 26%, cooling off after its massive stock price surge on Tuesday,...
Protagonist (PTGX) Up 14% on Licensing Deal With Takeda
Zacks via Yahoo Finance· 5 months agoPer the deal, Protagonist (PTGX) will grant exclusive rights to Takeda to market its late-stage rare...
Acadia (ACAD) Gets FDA Approval for Daybue for Rett Syndrome
Zacks via Yahoo Finance· 1 year agoAcadia Therapeutics (ACAD) announces the FDA approval of its Rett Syndrome drug, trofinetide, for...
GSK Lags Q4 Earnings, Tops Sales, Issues Upbeat '24 Guidance
Zacks via Yahoo Finance· 5 months agoGSK's revenues benefit from strong growth across all segments, especially the Shingles and RSV...